progressive relaxation exercises
BehavioralParticipants with menopausal symptoms received progressive relaxation exercise training, led by the responsible researcher who assigned them to the experimental group.
NCT Number: NCT07085078
Women typically enter menopause between the ages of 40 and 47, and they spend approximately one-third of their lives in this phase. During menopause, many experience hot flashes due to decreased estrogen levels, along with vasomotor changes such as altered heart rhythms and sleep disturbances. These issues may accompany or occur independently of hot flashes. Additionally, psychological changes can arise, including tension, sudden mood swings, anxiety, stress, and depression. Physiological concerns may include vaginal atrophy and stress incontinence.
Looking for future studies?
Notify Me45 year–65 year
Female
Interventional
Not applicable
Bursa Uludağ Üniversitesi, Nilufer, Bursa, Turkey (Türkiye)
Previous studies have shown that menopausal symptoms can significantly increase women's social appearance anxiety, depression, stress, and anxiety overall, negatively impacting their quality of life. Moreover, a limited number of recent studies have attempted to explore the relationship between the severity of menopausal symptoms in the workplace and factors such as job performance, career development decisions, and overall work participation.
This study aims to investigate the effects of progressive relaxation exercises on women's menopausal symptoms and their work performance.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants with menopausal symptoms received progressive relaxation exercise training, led by the responsible researcher who assigned them to the experimental group.
Time frame: Day 1 (During recruitment)
Evaluation of women using personal information.
This tool includes questions on women's sociodemographic characteristics
Time frame: Day 1 (during recruitment)
Evaluation of menopausal symptoms with Menopause Rating Scale (MRS). It is a Likert-type scale consisting of 11 items, including menopausal complaints. For each item, there are options of "0= None", "1= Mild", "2= Moderate", "3= Severe", and "4= Very severe". The lowest possible score is 0, the highest score is 44. An increase in the total score obtained from the scale indicates an increase in the severity of the complaints experienced.
Time frame: Day 1 (During recruitment)
Before intervention, participants are evaluated with the "Individual Work Performance Questionnaire"The scale was designed to measure job performance perception. It consists of 18 Likert-type items. A high score on the scale indicates that job performance perception has increased.
Time frame: Ten days after the conclusion of the five-week training program.
Evaluation of menopausal symptoms with Menopause Rating Scale (MRS). (The lowest possible score is 0, the highest score is 44. The increase in the total score obtained from the scale indicates an increase in the severity of the complaints).
Time frame: Ten days after the conclusion of the five-week training program.
participants are evaluated with the "Individual Work Performance Questionnaire" (The scale was designed to measure job performance perception. It consists of 18 Likert-type items. A high score on the scale indicates that job performance perception has increased.)
Aydin Adnan Menderes University
Other
Effects of Progressive Relaxation Exercise on Menopausal Symptoms and Work Performance: A Randomized Control Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06582433
Menopausal Depression, Menopause
Karabük, Karabük Province, Turkey (Türkiye)
View Trial DetailsNCT04079218
Aging, Aging, Premature
The Bronx, New York, United States
View Trial DetailsNCT06154798
Behavior, Behavioral Symptoms
Mumbai, Maharashtra, India
View Trial DetailsNCT05617287
Menopause, Menopause Related Conditions
Santa Monica, California, United States
View Trial Details